Dataset Information


The placental gene PEG10 promotes progression of neuroendocrine prostate cancer [Expression]

ABSTRACT: Neuroendocrine prostate cancer (NEPC) is proliferative, invasive, and untreatable. Its molecular pathogenesis remains poorly understood but appears to require TP53 and RB1 aberration. In this study we modeled the development of NEPC from conventional prostatic adenocarcinoma using a unique patient-derived xenograft and identified up-regulation of the placental gene PEG10. We found that the androgen receptor and the E2F/RB pathway dynamically regulate distinct post-transcriptional and post-translational isoforms of PEG10 at different stages of NEPC development. In vitro, PEG10 promoted cell cycle progression from G0/G1 in the context of TP53 loss, and regulated Snail expression via TGF-β signaling to promote invasion. Finally we show in vivo proof of principal using antisense oligonucleotide that PEG10 is a novel therapeutic target for NEPC. 14 patient-derived xenograft tumors from the LTL331 xenograft lineage (PMID: 24356420; after differing lengths of time post-host castration. Three replicates present for days 1-3 post-host castration.

ORGANISM(S): Homo sapiens  

SUBMITTER: Colin C Collins  Shawn Anderson   Alexander W Wyatt    

PROVIDER: E-GEOD-59984 | ArrayExpress | 2015-01-05



altmetric image


Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

| GSE59985 | GEO
2015-01-05 | E-GEOD-59985 | ArrayExpress
2015-01-15 | E-GEOD-61214 | ArrayExpress
2013-01-12 | E-GEOD-41188 | ArrayExpress
2013-01-12 | E-GEOD-41192 | ArrayExpress
2015-06-24 | E-GEOD-66187 | ArrayExpress
2013-04-20 | E-GEOD-46218 | ArrayExpress
| PRJNA358250 | ENA
2011-12-06 | E-GEOD-33316 | ArrayExpress
2014-02-14 | E-GEOD-54974 | ArrayExpress